Summit Therapeutics Inc. SMMT
- ivonescimab — Non-Small Cell Lung Cancer Phase 3
- ivonescimab — Colorectal Cancer Phase 3
- ivonescimab — Head and Neck Squamous Cell Carcinoma Phase 3
VEGF-A (1 companies · 3 programs)
Companies with an active program directed at VEGF-A.